key: cord-0763217-dk09mbru authors: Bertini, Matteo; Ferrari, Roberto; Rapezzi, Claudio title: What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients? date: 2020-12-08 journal: J Am Coll Cardiol DOI: 10.1016/j.jacc.2020.09.611 sha: a593deb5ee97c50c4f6ae5f77f6071cd9be665da doc_id: 763217 cord_uid: dk09mbru nan All authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page. We agree that ECG data are additive in helping to understand the nature of myocardial involvement and also holds prognostic relevance. Unfortunately, reviewing ECG data in our large cohort of patients (nearly 3,000) was not feasible within a reasonable timeframe to allow the dissemination of information that was of importance during a surge in COVID-19 cases across the globe. Furthermore, data were collected during the peak of the pandemic in New York City (February 27 to April 12, 2020), with variable uses of antiviral therapy, anticoagulation, and hydroxychloroquine, which may have influenced ECG information. Nonetheless, the message of our paper was simple and still holds true: myocardial injury is common, and when present, it portends worse prognosis among patients hospitalized with COVID-19. Myocardial injury is represented by elevated troponin concentrations based on the fourth universal definition of myocardial infarction (2). We acknowledge that Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection Electrocardiographic findings in coronavirus disease-19: insights on mortality and underlying myocardial processes consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Patrick O'Gara, MD, served as Guest Associate Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.